Rating History for Moonlake Immunotherapeutics (MLTX) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/15/2026 | Richard Law | Downgrade | Sell (Neutral) |
10.00 (8.00) |
17.10 (18.15) |
6.14% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
